New secoiridoids from Ligustrum ovalifolium and their hypotensive activity
1, 1, 1, 1
- 1Al-Azhar University, Faculty of Pharmacy, Pharmacognosy Department, Cairo, Egypt.
CORRESPONDENCE
Mohammed and Usama Y. Shaheen
Al-Azhar University, Faculty of Pharmacy, Pharmacognosy Department, Cairo, Egypt.
Received: 18-01-2009; Accepted: 14-02-2009.
Volume 1, Issue 2 · pp. 91-97 · 2009 · DOI:
ABSTRACT
New Secoiridoid glucosides 1-5; ligustaloside A methyl hemiacetal 1, ligustaloside B methyl hemiacetal 2, ligustaloside A dimethyl acetal 3 ligustaloside A butyl-methyl acetal 4, and ligustaloside B butyl hemiacetal 5 have been isolated from the leaves of Ligustrum ovalifolium L. along with five known secoiridoids; ligustaloside B dimethyl acetal 6, 10-hydroxy oleuropein 7, 10-hydroxy ligstroside 8, oleuropein 9 and ligstroside 10, one known iridoid; loganin 11 and two known phenethyl alcohol glucosides; 3,4-di hydroxyphenylethyl-β-D-glucoside 12 and p-hydroxyphenylethyl-β-D-glucoside 13. The structures have been elucidated by spectroscopic means including 1D NMR (1H, 13C, and DEPT), 2D NMR (COSY, HMQC and HMBC experiments), UV, IR and FAB-MS (positive mode). Both n-BuOH fraction and the isolated new compounds 1-5 were evaluated for their hypotensive activity on experimental animal. The n-BuOH fraction showed good activity; however, the activity of the isolated new compounds 1-5 did not particularly strong.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Hosny, M., Ragab, E. A., Mohammed, A. E. I., & Shaheen, U. Y. (2009). New secoiridoids from Ligustrum ovalifolium and their hypotensive activity. Pharmacognosy Research, 1(2), 91-97.
Copyright and licence
© 2009 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
